Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$15.06 USD
-0.27 (-1.76%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $15.07 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $0.45 | 0.00% |
Earnings Summary
For their last quarter, Catalyst Pharmaceuticals (CPRX) reported earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.34 per share. This reflects a positive earnings surprise of 11.76%. Look out for CPRX's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of $0.45 per share, reflecting a year-over-year increase of 36.36%.
Earnings History
Price & Consensus
Zacks News for CPRX
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
CPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services